Loading...
Generating destination analysis
Compass Direction
Earnings IntelligenceAI-Powered
Loading earnings analysis...
Compass Score
Neutral
Key Numbers
Market Cap
$170B
P/E
70
Revenue Growth
+17.0%
Gross Margin
N/A
ROE
N/A
About Intuitive Surgical
As a large-cap healthcare company trading on the NASDAQ, Intuitive Surgical has established itself, with indirect exposure to artificial intelligence and robotics through its adjacent operations. Robotic surgery pioneer using AI for surgical planning and autonomy. Valued at 70x trailing earnings with a $170B market capitalization, the company demonstrates consistent top-line gains at +17% year-over-year.
Expert Coverage
Unlock Full ISRG Analysis
Expert analysis and coverage for Intuitive Surgical
Or unlock everything now with Compass, $9/moPrice & Technical Analysis
Price50 DMA200 DMA
Price vs 200DMA
DMA Convergence
50 DMA
200 DMA
Rating last updated: 2026-08-16
More in AI & Robotics
META
Meta Platforms
86
True North
Mixed
Social media giant pivoting to AI-first strategy with Llama open-source models.
NASDAQ
MCap $1.5TRev +22%P/E 28SMCI
Super Micro Computer
85
True North
Pure Play
AI server and rack solutions optimized for GPU-intensive workloads.
NASDAQ
MCap $25BRev +110%P/E 18AVGO
Broadcom Inc.
84
True North
Mixed
Custom AI accelerator (ASIC) designer with VMware cloud software.
NASDAQ
MCap $800BRev +44%P/E 35CEG
Constellation Energy
81
True North
Mixed
Largest US nuclear fleet operator benefiting from clean energy and AI data center demand.
NASDAQ
MCap $75BRev +10%P/E 32More in Biotech & Genomics
LLY
Eli Lilly and Company
91
True North
Mixed
Pharma giant leading the GLP-1 revolution with Mounjaro and Zepbound weight-loss drugs.
NYSE
MCap $750BRev +32%P/E 65DXCM
DexCom Inc.
90
True North
Pure Play
Continuous glucose monitoring leader expanding beyond diabetes management.
NASDAQ
MCap $35BRev +20%P/E 55REGN
Regeneron Pharmaceuticals
88
True North
Pure Play
Biotech powerhouse with strong antibody pipeline and Dupixent franchise.
NASDAQ
MCap $100BRev +7%P/E 22ALNY
Alnylam Pharmaceuticals
88
True North
Pure Play
RNA interference therapeutics leader with approved treatments for rare diseases.
NASDAQ
MCap $30BRev +40%